[
DCMC Session
|
Presentation
]

Real-World Use-Cases for CMC Digitalization | Digital CMC Basecamp On-Demand | Presentation

Discover how drug developers can transition from legacy knowledge management to a connected data ecosystem.

See how to link control strategy development with automation and control system design.

Explore a Digital CMC approach to structuring and contextualizing primary data systems.

Learn how to integrate Digital CMC tools with downstream solutions to streamline clinical-commercial handoffs.

Session speakers

6 photos

Watch this session

Legend
Legend
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

We’re here to help you deliver

No items found.
[
QbDVision
]

Luke Guerrero

A veteran technologist and company leader with a global CV, Luke currently oversees the core business operations across QbDVision and its teams. Before joining QbDVision, he developed, grew, and led key practices for international agency Brand Networks, and spent six years deploying technology and business strategies for PricewaterhouseCoopers' CIO Advisory consulting unit.

[
Eli Lilly and Company
]

Victor Goetz

Victor is the Executive Director of Technical Services New Modalities and Data Strategy at Eli Lilly and Company. Leveraging his 35 years of industry experience in developing and commercializing nine novel medicines to enhance the exchange of knowledge needed to speed delivery of new medicines to patients. Previous to Lilly, he held process development, manufacturing support, and laboratory automation roles at Merck and holds a BS in chemical engineering from Stanford University and a PhD in chemical and biochemical engineering from the University of Pennsylvania.

[
Zaether
]

Chris Puzzo

Chris is a Solution Architect with Zaether, focusing on delivering next-generation digital and data solutions for GxP Life Sciences customers. Chris has previously held technical operations roles within multiple gene therapy manufacturers, including Thermo Fisher Scientific's CDMO organization where he supported various capital projects including the design, build, and startup of new GxP manufacturing capacity.

[
AbbVie
]

Diana Bowley

Diana is the Associate Director, Data & Digital Strategy in S&T-Biologics Development and Launch leading the organization's Digital Transformation since October 2021. She joined AbbVie in 2012 in the R&D-Discovery Biologics group focused on antibody and multi-specific protein screening and engineering, leading multiple programs to the cell line development stage. In 2017 she joined Information Research and led a team of IT professionals who supported AbbVie's Discovery Scientists in Biotherapeutics, Chemistry, Immunology and Neuroscience. She has a PhD in Molecular Biology from The Scripps Research Institute and Bachelor of Science in Chemistry from The University of Northern Iowa.